Subtype
Nasopharyngeal Neoplasm
CI-CAN-00003401Explore in graph →
Non-malignant267 active trials1 approved drugs
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003401Explore in graph →
Clinical trials
825 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01256853 | Modified Vaccinia Ankara (MVA) Vaccine Study | completed | Phase 1 | 18 | Chinese University of Hong KongOTHER | 1 | Dec 22, 2011 | clinicaltrials |
| NCT01479504 | A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 2 | Guangxi Medical UniversityOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01449942 |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) |
| completed |
| Phase 1 / Phase 2 |
| 40 |
| Xiangya Hospital of Central South UniversityOTHER |
| 1 |
| Oct 10, 2011 |
| clinicaltrials |
| NCT01182909 | Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC) | unknown | — | 4,000 | Far Eastern Memorial HospitalOTHER | 1 | Sep 19, 2011 | clinicaltrials |
| NCT01086488 | Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma(FOSCAN) | unknown | Phase 2 | 66 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00563862 | Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0) | terminated | N/A | 465 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jun 16, 2011 | clinicaltrials |
| NCT01312311 | Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer | unknown | Phase 2 | 51 | Samsung Medical CenterOTHER | 1 | Mar 10, 2011 | clinicaltrials |
| NCT01265147 | Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma | unknown | Phase 2 | 20 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00436293 | Taxotere + Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 2 | 61 | SanofiINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00363831 | Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 42 | The University of Hong KongOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00563927 | Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0) | unknown | N/A | 340 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00201344 | A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients | terminated | Phase 3 | 320 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 26, 2010 | clinicaltrials |
| NCT00700440 | Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy(ENCORE) | completed | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 26, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00436800 | Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00173836 | Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount | completed | — | 122 | National Taiwan University HospitalOTHER | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)(TPF for NPC) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00817258 | Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | unknown | Phase 2 | 64 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | unknown | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00078494 | Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | completed | Phase 1 | 99 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00364962 | Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients | unknown | — | 20 | National Taiwan University HospitalOTHER | 1 | Aug 16, 2006 | clinicaltrials |
| NCT00304694 | Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients | unknown | — | 50 | National Taiwan University HospitalOTHER | 1 | Mar 20, 2006 | clinicaltrials |
| NCT00155181 | Molecular Mechanism of Nasopharyngeal Carcinoma | unknown | — | 25 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Dec 22, 2011source: clinicaltrials